Republic Healthcare Limited
Republic Healthcare Limited (8357.HK) Stock Overview
Explore Republic Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
93.6M
P/E Ratio
-86.59
EPS (TTM)
$-0.01
ROE
-0.01%
8357.HK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Republic Healthcare Limited (8357.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.07.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -86.59 and a market capitalization of 93.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexual health and infectious diseases. It also provides treatment solutions for common skin conditions and basic medical aesthetics services. The company operates nine clinics under the Dr. Tan & Partners brand name; and one clinic under the S Aesthetics brand name. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.
Cher Sen Tan
34
No. 16-05 Shaw Centre, Singapore
2018